Atlas Trials

High Risk Hematologic Malignancies

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Risk Hematologic Malignancies

RecordFirmDate
Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia (NCT05445765)iCell Gene Therapeutics2022-07-01
Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies (NCT01818479)University of Utah2013-07-12

Track High Risk Hematologic Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.